Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Infect Dis (Lond) ; 52(3): 196-201, 2020 03.
Article in English | MEDLINE | ID: mdl-31778089

ABSTRACT

Introduction:Clostridium perfringens and other gas gangrene-forming clostridia are commensals of the human gut and vaginal microbiota, but can cause serious or even fatal infections. As there are relatively few published studies on antibiotic susceptibility of these bacteria, we decided to perform a 10-year retrospective study in a South-Eastern Hungarian clinical centre.Methods: A total of 372 gas gangrene-forming Clostridium spp. were isolated from clinically relevant samples and identified with rapid ID 32A (bioMérieux, France) and MALDI-TOF MS (Bruker Daltinics, Germany) methods. Antibiotic susceptibility was determined with E-tests.Results: We identified 313 C. perfringens, 20 C. septicum, 10 C. sordellii, 10 C. sporogenes, 9 C. tertium, 6 C. bifermentans, 4 C. histolyticum isolates. In C. perfringens isolates, the rate of penicillin resistance was 2.6% and the rate of clindamycin resistance 3.8%. Penicillin resistance was found in 6.8% and clindamycin resistance in 8.5% of the non-perfringens Clostridium spp. isolates.Conclusion: The antibiotic susceptibility of C. perfringens isolates was in good agreement with previous publications. The rates of resistance to penicillin and clindamycin were very low. The resistance rates of non-perfringens Clostridium spp. isolates were higher than those of C. perfringens strains, but lower than those published in the literature.


Subject(s)
Anti-Bacterial Agents/pharmacology , Clindamycin/pharmacology , Clostridium/drug effects , Gas Gangrene/microbiology , Penicillins/pharmacology , Adolescent , Adult , Aged , Aged, 80 and over , Amoxicillin-Potassium Clavulanate Combination/pharmacology , Cefoxitin/pharmacology , Child , Child, Preschool , Clostridium/isolation & purification , Clostridium bifermentans/drug effects , Clostridium bifermentans/isolation & purification , Clostridium histolyticum/drug effects , Clostridium histolyticum/isolation & purification , Clostridium perfringens/drug effects , Clostridium perfringens/isolation & purification , Clostridium septicum/drug effects , Clostridium septicum/isolation & purification , Clostridium sordellii/drug effects , Clostridium sordellii/isolation & purification , Clostridium tertium/drug effects , Clostridium tertium/isolation & purification , Drug Resistance, Bacterial , Female , Gas Gangrene/drug therapy , Humans , Hungary , Imipenem/pharmacology , Infant , Inhibitory Concentration 50 , Male , Meropenem/pharmacology , Microbial Sensitivity Tests , Middle Aged , Retrospective Studies , Tigecycline/pharmacology , Young Adult
2.
BMC Microbiol ; 19(1): 53, 2019 03 04.
Article in English | MEDLINE | ID: mdl-30832583

ABSTRACT

BACKGROUND: With the current rise of antibiotic resistance in bacteria, it is important to monitor the efficacy of antimicrobials in clinical use. Paeniclostridium sordellii (previously Clostridium sordellii) is a bacterial pathogen that causes human uterine infection after spontaneous or medically induced abortion, for which mortality rates approach 100%. Prophylactic antibiotics have been recommended for individuals undergoing medically-induced abortion, one of which is doxycycline, a member of the tetracycline antibiotic family. However, tetracycline resistance had not been well characterized in P. sordellii. This study therefore aimed to determine the levels of tetracycline resistance in P. sordellii isolates, and to identify associated loci and their genomic locations. RESULTS: Using a MIC assay, five of 24 P. sordellii isolates were found to be resistant to tetracycline, minocycline, and importantly, doxycycline. Analysis of genome sequence data from 46 isolates found that phenotypically resistant isolates encoded a variant of the Clostridium perfringens tetracycline resistance determinant Tet P. Bioinformatic analysis and comparison of the regions surrounding these determinants found variation in the genomic location of Tet P among P. sordellii isolates. The core genome comparison of the 46 isolates revealed genetic diversity and the absence of dominant genetic types among the isolates. There was no strong association between geographic location of isolation, animal host or Tet P carriage with isolate genetic type. Furthermore, the analysis of the Tet P genotype revealed that Tet P is encoded chromosomally, or on one of two, novel, small plasmids, all consistent with multiple acquisition and recombination events. BLAST analysis of Clostridioides difficile draft genome sequences also identified a Tet P locus, the genomic location of which demonstrated an evolutionary relationship with the P. sordellii locus. CONCLUSIONS: The Tet P determinant is found in variable genomic locations within diverse human and animal isolates of P. sordellii and C. difficile, which suggests that it can undergo horizontal transfer, and may disseminate tetracycline resistance between clostridial species. Doxycycline is a suggested prophylactic treatment for P. sordellii infections, however, a small sub-set of the isolates tested are resistant to this antibiotic. Doxycycline may therefore not be an appropriate prophylactic treatment for P. sordellii infections.


Subject(s)
Clostridioides difficile/genetics , Clostridium sordellii/genetics , Genetic Loci , Genome, Bacterial , Tetracycline Resistance/genetics , Anti-Bacterial Agents/pharmacology , Clostridioides difficile/drug effects , Clostridium sordellii/drug effects , Doxycycline/pharmacology , Microbial Sensitivity Tests , Tetracycline/pharmacology
3.
Res Microbiol ; 166(4): 368-74, 2015 May.
Article in English | MEDLINE | ID: mdl-25290059

ABSTRACT

Clostridium sordellii is gram positive bacterial pathogen of humans and animals. While the incidence of human-related C. sordellii infection is low, the mortality rate associated with infection is high. Of particular concern are C. sordellii infections after child-birth or medical abortion, which have an almost 100% mortality rate. Recent genetic and epidemiological work has increased our understanding of how this pathogen has evolved and how it causes disease. This review will summarise studies involving the genetics of C. sordellii, including an antibiotic resistance profile, the genetic determinants of virulence and mutagenesis of C. sordellii.


Subject(s)
Clostridium sordellii/drug effects , Clostridium sordellii/genetics , Drug Resistance, Bacterial , Virulence Factors/genetics , Animals , Clostridium Infections/epidemiology , Clostridium Infections/microbiology , Clostridium Infections/veterinary , Humans , Incidence , Survival Analysis
4.
Cell Microbiol ; 12(2): 217-32, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19840028

ABSTRACT

Inactivation of different small GTPases upon their glucosylation by lethal toxin from Clostridium sordellii strain IP82 (LT-82) is already known to lead to cell rounding, adherens junction (AJ) disorganization and actin depolymerization. In the present work, we observed that LT-82 induces a rapid dephosphorylation of paxillin, a protein regulating focal adhesion (FA), independently of inactivation of paxillin kinases such as Src, Fak and Pyk2. Among the small GTPases inactivated by this toxin, including Rac, Ras, Rap and Ral, we identified Rac1, as responsible for paxillin dephosphorylation using cells overexpressing Rac1(V12). Rac1 inactivation by LT-82 modifies interactions between proteins from AJ and FA complexes as shown by pull-down assays. We showed that in Triton X-100-insoluble membrane proteins from these complexes, namely E-cadherin, beta-catenin, p120-catenin and talin, are decreased upon LT-82 intoxication, a treatment that also induces a rapid decrease in cell phosphoinositide content. Therefore, we proposed that Rac inactivation by LT-82 alters phosphoinositide metabolism leading to FA and AJ complex disorganization and actin depolymerization.


Subject(s)
Actins/metabolism , Bacterial Toxins/pharmacology , Clostridium sordellii/drug effects , Clostridium sordellii/metabolism , Focal Adhesions/drug effects , Focal Adhesions/metabolism , rac1 GTP-Binding Protein/metabolism , Electrophoresis, Polyacrylamide Gel , HeLa Cells , Humans , Immunoblotting , Immunoprecipitation , Microscopy, Confocal , Microscopy, Phase-Contrast , Protein Binding/drug effects
6.
J Immunol ; 180(12): 8222-30, 2008 Jun 15.
Article in English | MEDLINE | ID: mdl-18523288

ABSTRACT

Fatal cases of acute shock complicating Clostridium sordellii endometritis following medical abortion with mifepristone (also known as RU-486) used with misoprostol were reported. The pathogenesis of this unexpected complication remains enigmatic. Misoprostol is a pharmacomimetic of PGE(2), an endogenous suppressor of innate immunity. Clinical C. sordellii infections were associated with intravaginal misoprostol administration, suggesting that high misoprostol concentrations within the uterus impair immune responses against C. sordellii. We modeled C. sordellii endometritis in rats to test this hypothesis. The intrauterine but not the intragastric delivery of misoprostol significantly worsened mortality from C. sordellii uterine infection, and impaired bacterial clearance in vivo. Misoprostol also reduced TNF-alpha production within the uterus during infection. The intrauterine injection of misoprostol did not enhance mortality from infection by the vaginal commensal bacterium Lactobacillus crispatus. In vitro, misoprostol suppressed macrophage TNF-alpha and chemokine generation following C. sordellii or peptidoglycan challenge, impaired leukocyte phagocytosis of C. sordellii, and inhibited uterine epithelial cell human beta-defensin expression. These immunosuppressive effects of misoprostol, which were not shared by mifepristone, correlated with the activation of the G(s) protein-coupled E prostanoid (EP) receptors EP2 and EP4 (macrophages) or EP4 alone (uterine epithelial cells). Our data provide a novel explanation for postabortion sepsis leading to death and also suggest that PGE(2), in which production is exaggerated within the reproductive tract during pregnancy, might be an important causal determinant in the pathogenesis of more common infections of the gravid uterus.


Subject(s)
Clostridium Infections/immunology , Clostridium sordellii/drug effects , Clostridium sordellii/immunology , Disease Models, Animal , Endometritis/immunology , Endometritis/microbiology , Immunity, Innate/drug effects , Misoprostol/adverse effects , Animals , Cell Line , Clostridium sordellii/pathogenicity , Endometritis/mortality , Female , Humans , Immunosuppressive Agents/administration & dosage , Immunosuppressive Agents/adverse effects , Inflammation Mediators/antagonists & inhibitors , Inflammation Mediators/physiology , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/immunology , Macrophages, Peritoneal/metabolism , Mice , Mice, Inbred CBA , Misoprostol/administration & dosage , Rats , Rats, Wistar , Virulence/drug effects , Virulence/immunology
7.
J Med Microbiol ; 57(Pt 6): 745-749, 2008 Jun.
Article in English | MEDLINE | ID: mdl-18480332

ABSTRACT

Clostridium difficile is an important nosocomial pathogen, resulting in antibiotic-associated disease ranging from mild diarrhoea to the life-threatening pseudomembranous colitis. Upon antibiotic exposure, it is believed that the normal bowel microflora of patients is disrupted, allowing C. difficile to proliferate. Significantly, C. difficile is among only a few bacteria able to ferment tyrosine to p-cresol, a phenolic compound that is toxic to other microbes via its ability to interfere with metabolism. Therefore, the ability of different C. difficile strains to produce and tolerate p-cresol may play an important role in the development and severity of C. difficile-associated disease. In this study, it was demonstrated that two C. difficile hypervirulent 027 strains (Stoke Mandeville and BI-16) are more tolerant to p-cresol than other C. difficile strains including 630, CF4 and CD196. Surprising, it was shown that Clostridium sordellii also has a high tolerance to p-cresol, suggesting an overlap in the tolerance pathways in these clostridial species.


Subject(s)
Clostridioides difficile/drug effects , Cresols/pharmacology , Drug Resistance, Bacterial/physiology , Clostridioides difficile/classification , Clostridioides difficile/growth & development , Clostridium perfringens/drug effects , Clostridium sordellii/drug effects , Dose-Response Relationship, Drug , Humans
SELECTION OF CITATIONS
SEARCH DETAIL
...